MedTrace Logo

Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events

NCT02074085 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2014-02-28

No results posted yet for this study

Summary

An ADE is defined as harm caused by a drug or the inappropriate use of a drug. Retrospective record reviews in several countries have shown that anticoagulants frequently lead to hospital readmissions. In this study a hospital readmission is defined as an admission to the emergency department of the Jessa hospital. The objective of this study is to determine the incidence of one week and 30-day readmissions caused by (preventable) ADE's due to anticoagulants.

Conditions

  • Incidence of Readmissions
  • ADE's Due to Anticoagulants

Sponsors & Collaborators

  • Jessa Hospital

    collaborator OTHER

  • Hasselt University

    lead OTHER

Principal Investigators

  • Martijn Droogmans, pharmacist · Jessa Hospital

  • Kristel Marquet, drs · Hasselt University

  • Janne Theuwissen, pharmacist · Jessa Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02074085 on ClinicalTrials.gov